Screening, treatment initiation, and referral for substance use disorders

Area of Science:

• Public Health
• Clinical Medicine
• Addiction Science

Background:

• Substance use disorders are a major global health crisis, necessitating effective interventions.
• Screening, Brief Intervention, and Referral to Treatment (SBIRT) has been a cornerstone for addressing unhealthy alcohol use.
• Existing SBIRT models show variable efficacy, highlighting the need for innovative approaches.

Discussion:

• A new model, Screening, Treatment Initiation, and Referral (STIR), integrates immediate medication management with screening and counseling.
• STIR trials demonstrated success in achieving sustained abstinence in smokers and improved treatment engagement in opioid-dependent individuals.
• This approach addresses limitations of traditional SBIRT by facilitating timely access to pharmacotherapy.

Key Insights:

• STIR significantly improved biochemically confirmed abstinence rates in adult smokers undergoing nicotine pharmacotherapy.
• Initiation of buprenorphine via STIR led to higher treatment engagement and self-reported abstinence in opioid-dependent patients.
• The STIR model demonstrates clinical effectiveness in diverse substance use populations.

Outlook:

• STIR holds potential as a scalable and effective strategy for substance use treatment in various clinical settings.
• Further research can explore STIR's applicability to a broader range of substance use disorders.
• Optimizing healthcare systems for STIR implementation is crucial for widespread adoption and impact.